07/18/2025
3:46 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2025
4:14 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:21 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
4:06 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:08 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:08 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:09 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:25 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:08 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:08 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:09 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for ONC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BeOne Medicines and its competitors with MarketBeat's FREE daily newsletter. |
06/18/2025
4:12 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:49 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:51 PM | Ball Titus B. (Reporting)
BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:38 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:39 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:42 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:44 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:45 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:15 PM | Ball Titus B. (Reporting)
BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
3:54 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:13 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
3:16 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
11:15 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
05/27/2025
3:52 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POSASR | |
05/27/2025
3:52 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POSASR | |
05/27/2025
3:26 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POS AM | |
05/27/2025
7:35 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K12G3 | |
05/26/2025
11:15 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Riva Alessandro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:46 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
BRANDICOURT OLIVIER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:47 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:41 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
HOOPER ANTHONY C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:42 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Dugan Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:45 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:37 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:53 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Capital International Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
5:04 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
5:09 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:09 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad) This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto.
Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin |
04/28/2025
7:26 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
4:12 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:21 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
5:12 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form ARS | |
04/07/2025
5:03 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEF 14A | |
04/07/2025
5:07 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEFA14A | |
04/01/2025
3:27 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:53 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:51 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:43 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:51 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144/A | |
03/10/2025
3:19 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:08 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEFA14A | |
03/09/2025
11:15 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
03/10/2025
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 424B3 | |
03/07/2025
7:17 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:26 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:19 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:20 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:22 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:24 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:14 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
4:22 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:48 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:07 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:30 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SCHEDULE 13D/A | |
03/03/2025
8:31 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:30 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:49 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
8:43 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:40 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:28 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K/A | |
02/28/2025
5:15 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form S-4/A | |
02/27/2025
5:04 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
5:12 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
3:23 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:24 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Lee Chan Henry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
5:12 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:29 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
3:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:02 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:08 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K/A | |
01/07/2025
3:18 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
5:05 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:02 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:18 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:25 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad) This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto.
Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin |
12/10/2024
8:30 PM | BAKER BROS. ADVISORS LP (Filed by)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form SC 13D/A | |
12/10/2024
7:19 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:26 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:48 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
8:48 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
8:45 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
3:31 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:23 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
